Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HEPACAM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ZNF222 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PLEKHG3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | DPF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | HSPD1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ZNF225 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ORAOV1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SGMS1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PCDHB9 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | RP3-461F17.3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |